BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value: $514M (94.8% shares, 5.2% debt)

Holdings (31)

IRWD IRONWOOD PHARMACEUTICALS INC 15.2%

Value $78.04M Shares 5,093,810 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 11.4%

Value $58.72M Shares 8,596,772 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 10.8%

Value $55.68M Shares 11,772,335 Est. Cost — Unrealized —

LGND LIGAND PHARMACEUTICALS INC 8.9%

Value $45.76M Shares 860,063 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 5.8%

Value $29.92M Shares 1,374,815 Est. Cost — Unrealized —

— ONCOTHYREON INC 5.1%

Value $26.15M Shares 13,762,260 Est. Cost — Unrealized —

— FIVE PRIME THERAPEUTICS INC 4.3%

Value $22.31M Shares 826,332 Est. Cost — Unrealized —

— FORWARD PHARMA A/S 4.3%

Value $21.92M Shares 1,052,381 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 3.8%

Value $19.57M Shares 2,443,100 Est. Cost — Unrealized —

— EXELIXIS INC 3.5%

Value $18.09M Shares 31,239,000 Est. Cost — Unrealized —

— TARGACEPT INC 3.4%

Value $17.5M Shares 6,655,128 Est. Cost — Unrealized —

— CONCERT PHARMACEUTICALS INC 3.1%

Value $16.07M Shares 1,206,459 Est. Cost — Unrealized —

— LOXO ONCOLOGY INC 2.7%

Value $13.99M Shares 1,190,702 Est. Cost — Unrealized —

— VITAE PHARMACEUTICALS INC 2.4%

Value $12.54M Shares 753,935 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 2.4%

Value $12.21M Shares 618,224 Est. Cost — Unrealized —

— QLT INC 2.1%

Value $10.63M Shares 2,650,563 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 1.6%

Value $8.477M Shares 9,000,000 Est. Cost — Unrealized —

— GTX INC DEL 1.6%

Value $8.111M Shares 11,111,111 Est. Cost — Unrealized —

— SUNESIS PHARMACEUTICALS INC 1.6%

Value $7.997M Shares 3,136,000 Est. Cost — Unrealized —

EXEL EXELIXIS INC 1.2%

Value $6.041M Shares 4,195,352 Est. Cost — Unrealized —

— ARQULE INC 1.1%

Value $5.763M Shares 4,723,811 Est. Cost — Unrealized —

— MAST THERAPEUTICS INC 0.8%

Value $4.083M Shares 7,291,600 Est. Cost — Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.6%

Value $3.134M Shares 1,368,500 Est. Cost — Unrealized —

— BIOLINERX LTD 0.5%

Value $2.432M Shares 1,501,000 Est. Cost — Unrealized —

— KALOBIOS PHARMACEUTICALS INC 0.4%

Value $2.01M Shares 1,162,000 Est. Cost — Unrealized —

— ACHAOGEN INC 0.3%

Value $1.783M Shares 136,600 Est. Cost — Unrealized —

— REGADO BIOSCIENCES INC 0.3%

Value $1.719M Shares 1,882,521 Est. Cost — Unrealized —

— APTOSE BIOSCIENCES INC 0.2%

Value $986K Shares 166,664 Est. Cost — Unrealized —

— BIOTA PHARMACEUTIALS INC 0.2%

Value $976K Shares 435,900 Est. Cost — Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.2%

Value $884K Shares 559,624 Est. Cost — Unrealized —

— SOPHIRIS BIO INC 0.1%

Value $573K Shares 1,060,283 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IRWD	IRONWOOD PHARMACEUTICALS INC	5,093,810	$78.04M	15.2%	—	—	COM CL A	46333X108
—	CHEMOCENTRYX INC	8,596,772	$58.72M	11.4%	—	—	COM	16383L106
—	ARRAY BIOPHARMA INC	11,772,335	$55.68M	10.8%	—	—	COM	04269X105
LGND	LIGAND PHARMACEUTICALS INC	860,063	$45.76M	8.9%	—	—	COM NEW	53220K504
—	ONCOMED PHARMACEUTICALS INC	1,374,815	$29.92M	5.8%	—	—	COM	68234X102
—	ONCOTHYREON INC	13,762,260	$26.15M	5.1%	—	—	COM	682324108
—	FIVE PRIME THERAPEUTICS INC	826,332	$22.31M	4.3%	—	—	COM	33830X104
—	FORWARD PHARMA A/S	1,052,381	$21.92M	4.3%	—	—	SPONSORED ADR	34986J105
CYTK	CYTOKINETICS INC	2,443,100	$19.57M	3.8%	—	—	COM NEW	23282W605
—	EXELIXIS INC	31,239,000	$18.09M	3.5%	—	—	NOTE 4.250% 8/1	30161QAC8
—	TARGACEPT INC	6,655,128	$17.5M	3.4%	—	—	COM	87611R306
—	CONCERT PHARMACEUTICALS INC	1,206,459	$16.07M	3.1%	—	—	COM	206022105
—	LOXO ONCOLOGY INC	1,190,702	$13.99M	2.7%	—	—	COM	548862101
—	VITAE PHARMACEUTICALS INC	753,935	$12.54M	2.4%	—	—	COM	92847N103
XENE	XENON PHARMACEUTICALS INC	618,224	$12.21M	2.4%	—	—	COM	98420N105
—	QLT INC	2,650,563	$10.63M	2.1%	—	—	COM	746927102
—	ARRAY BIOPHARMA INC	9,000,000	$8.477M	1.6%	—	—	NOTE 3.000% 06/0	04269XAA3
—	GTX INC DEL	11,111,111	$8.111M	1.6%	—	—	COM	40052B108
—	SUNESIS PHARMACEUTICALS INC	3,136,000	$7.997M	1.6%	—	—	COM NEW	867328601
EXEL	EXELIXIS INC	4,195,352	$6.041M	1.2%	—	—	COM	30161Q104
—	ARQULE INC	4,723,811	$5.763M	1.1%	—	—	COM	04269E107
—	MAST THERAPEUTICS INC	7,291,600	$4.083M	0.8%	—	—	COM	576314108
—	ONCOGENEX PHARMACEUTICALS IN	1,368,500	$3.134M	0.6%	—	—	COM	68230A106
—	BIOLINERX LTD	1,501,000	$2.432M	0.5%	—	—	SPONSORED ADR	09071M106
—	KALOBIOS PHARMACEUTICALS INC	1,162,000	$2.01M	0.4%	—	—	COM	48344T100
—	ACHAOGEN INC	136,600	$1.783M	0.3%	—	—	COM	004449104
—	REGADO BIOSCIENCES INC	1,882,521	$1.719M	0.3%	—	—	COM	75874Q107
—	APTOSE BIOSCIENCES INC	166,664	$986K	0.2%	—	—	COM NEW	03835T200
—	BIOTA PHARMACEUTIALS INC	435,900	$976K	0.2%	—	—	COM	090694100
—	ANTHERA PHARMACEUTICALS INC	559,624	$884K	0.2%	—	—	COM NEW	03674U201
—	SOPHIRIS BIO INC	1,060,283	$573K	0.1%	—	—	COM NEW	83578Q209